Document is current
Any future updates will be listed below
-
Authors
Yoshii, Akira
Nagoshi, Tomohisa https://orcid.org/0000-0002-8980-881X
Kashiwagi, Yusuke
Kimura, Haruka
Tanaka, Yoshiro
Oi, Yuhei
Ito, Keiichi
Yoshino, Takuya
Tanaka, Toshikazu D.
Yoshimura, Michihiro
-
Funding
Funding for this research was provided by:
Grants-in-aid for the Ministry of Education, Culture, Sports, Science and Technology (JP17K09531)
- License Information
-
More Information
Article History
Received: 22 March 2019
Accepted: 23 June 2019
First Online: 1 July 2019
Ethics approval and consent to participate
: All animal procedures conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Research Committee at the Jikei University School of Medicine (2016-038C4).
: Not applicable.
: Michihiro Yoshimura reports that there are any relevant conflicts of interest. Outside the submitted work, there are personal fees from Mochida Pharmaceutical Co., Ltd, personal fees from MSD K.K., grants and personal fees from Kyowa Hakko Kirin Co., Ltd., grants and personal fees from Pfizer Japan Inc., grants and personal fees from Daiichi Sankyo Healthcare Co., Ltd., grants and personal fees from Sumitomo Dainippon Pharma Co., Ltd., grants from Nippon Boehringer Ingelheim Co., Ltd., grants from Otsuka Pharmaceutical Co., Ltd., grants from Teijin Pharma Limited, personal fees from Fujiyakuhin Co., Ltd., grants and personal fees from AstraZeneca K.K., personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants from Astellas Pharma Inc., personal fees from Mitsubishi Tanabe Pharma Corporation, grants from Shionogi & Co., Ltd., grants from Ono Pharmaceutical Co., Ltd. Tomohisa Nagoshi also reports that there are any relevant conflicts of interest. Outside the submitted work, there are grants from Daiichi Sankyo Healthcare Co., Ltd., from Nippon Boehringer Ingelheim Co., Ltd., and from Mitsubishi Tanabe Pharma Corporation.
